Defining these mutations is the first step in developing targeted therapies for lung cancer.
Dr. Major is an assistant professor in the Cancer Cell Biology program. Dr. Hayes is an associate professor in the division of Hematology/Oncology. Both are members of UNC Lineberger.
Since 2006, Triad Golfers Against Cancer has given UNC Lineberger $536,000 for innovative cancer research projects.
Read related story in The Business Journal.